mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.7 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.7 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |